Isono M, Okubo K, Asano T, Sato A. Ataxia telangiectasia and Rad3-related inhibition by AZD6738 enhances gemcitabine-induced cytotoxic effects in bladder cancer cells. PLOS ONE. 2022. 17. 4. e0266476-e0266476
Okubo K, Reßing N, Schulz WA, Hansen FK, Asano T, Sato A. The dual histone deacetylase-proteasome inhibitor RTS-V5 acts synergistically with ritonavir to induce endoplasmic reticulum stress in bladder cancer cells. Anticancer Research. 2021. 41. 12. 5987-5996
Okubo K, Miyai K, Kato K, Asano T, Sato A. Simvastatin-romidepsin combination kills bladder cancer cells synergistically. Translational Oncology. 2021. 14. 9. 101154-101154
Okubo K, Isono M, Asano T, Reßing N, Schulz WA, Hansen FK, Sato A. Ubiquitin-proteasome system is a promising target for killing cisplatin-resistant bladder cancer cells. Anticancer Research. 2021. 41. 6. 2901-2912
Isono M, Okubo K, Asano T, Sato A. Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells. Scientific Reports. 2021. 11. 1. 10181
Asano Takako, Sato Akinori, Okubo Kazuki, Isono Makoto, Asano Tomohiko. RITONAVIR AND IXAZOMIB INHIBIT RENAL CANCER GROWTH IN VITRO AND IN VIVO BY INDUCING ENDOPLASMIC RETICULUM STRESS SYNERGISTICALLY. JOURNAL OF UROLOGY. 2018. 199. 4. E955